Zobrazeno 1 - 10
of 403
pro vyhledávání: '"de la Brassinne, M."'
Autor:
Quiles-Tsimaratos, N., Paul, C., De La Brassinne, M., Telle-Sauvant, H., Corgibet-Escallier, F., Tanasescu, S., Roux, B., Girardot-Seguin, S., Duval-Modeste, A.-B.
Publikováno v:
In Annales de Dermatologie et de Vénéréologie March 2023 150(1):28-34
Autor:
Grine, L, de la Brassinne, M, Ghislain, P-D, Hillary, T, Lambert, J, Segaert, S, Willaert, F, Farida, Benhadou, Chantal, Bonardeaux, Hugo, Boonen, Audrey, Henno, Sven, Lanssens, Arjen, Nikkels F, Annelies, Stockman, Erwin, Suys, Linda, Temmerman, Mark, Vandaele, Karen, Vermeersch
Publikováno v:
Journal of the European Academy of Dermatology and Venereology
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
Journal of the European Academy of Dermatology and Venereology, Vol. 34, no. 4, p. 676-684 (2020)
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
Journal of the European Academy of Dermatology and Venereology, Vol. 34, no. 4, p. 676-684 (2020)
OBJECTIVE: Treat-to-target (T2T) is an algorithm to reach a predefined outcome. Here, we define a T2T outcome for moderate-to-severe psoriasis vulgaris. METHODS: Briefly, the study included a literature review, discussions with key opinion leaders, r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2112f6dc38bae8badbc14a92342648c9
https://lirias.kuleuven.be/handle/20.500.12942/694761
https://lirias.kuleuven.be/handle/20.500.12942/694761
Publikováno v:
In Annales de dermatologie et de venereologie 2007 134(4) Part 1:402-404
Autor:
Henno, A., De La Brassinne, M.
Publikováno v:
In Annales de dermatologie et de venereologie 2004 131(6) Part 1:599-605
Autor:
Quiles-Tsimaratos, N., Paul, C., De La Brassinne, M., Telle-Sauvant, H., Corgibet-Escallier, F., Tanasescu, S., Roux, B., Moumane, S.-H., Duval-Modeste, A.-B.
Publikováno v:
In Annales de Dermatologie et de Vénéréologie December 2020 147(12) Supplement:A363-A363
Publikováno v:
In Annales de dermatologie et de venereologie 2006 133(12):1009-1010
Publikováno v:
In Annales de dermatologie et de venereologie 2006 133(1):71-72
This post-approval, open-label trial (n = 1266) assessed the efficacy of efalizumab, administered in accordance with the European label at that time, in patients with concomitant nail, scalp or palmoplantar psoriasis. Patients received subcutaneous e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::2aea097c219f052ddc972c4d571af822
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3061996
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3061996
Publikováno v:
Papp, K, Berth-Jones, J, Kragballe, K, Wozel, G & de la Brassinne, M 2007, ' Scalp psoriasis : a review of current topical treatment options ', Journal of the European Academy of Dermatology and Venereology, vol. 21, no. 9, pp. 1151-60 . https://doi.org/10.1111/j.1468-3083.2007.02424.x
Papp, K, Berth-Jones, J, Kragballe, K, Wozel, G & de la Brassinne, M 2007, ' Scalp psoriasis: a review of current topical treatment options ', J Eur Acad Dermatol Venereol., vol. 21, no. 9, pp. 1151-60 .
Papp, K, Berth-Jones, J, Kragballe, K, Wozel, G & de la Brassinne, M 2007, ' Scalp psoriasis: a review of current topical treatment options ', J Eur Acad Dermatol Venereol., vol. 21, no. 9, pp. 1151-60 .
The scalp is the most common site of disease involvement at the onset and throughout the course of psoriasis. For many patients, psoriasis of the scalp is the most difficult aspect of their disease; yet, despite a wide range of therapy options and an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7c2245c5e82fe42713f362faf8a2bc2e
https://pure.au.dk/portal/da/publications/scalp-psoriasis(61848762-4de3-47c5-819f-f5188c31a2de).html
https://pure.au.dk/portal/da/publications/scalp-psoriasis(61848762-4de3-47c5-819f-f5188c31a2de).html
Autor:
Kragballe, Knud, Austad, J, Barnes, L, Bibby, A, de la Brassinne, M, Cambazard, F, Flemming, C, Heikkilä, H, Jolliffe, D, Peyri, J, Svensson, Å, Toole, J, Wozel, G
Publikováno v:
Kragballe, K, Austad, J, Barnes, L, Bibby, A, de la Brassinne, M, Cambazard, F, Flemming, C, Heikkilä, H, Jolliffe, D, Peyri, J, Svensson, Å, Toole, J & Wozel, G 2006, ' A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet ® /Daivobet ® /Taclonex ® ) in the treatment of psoriasis vulgaris ', Br. J. Dermatol., no. 154, pp. 1155-1160 .
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pure_au_____::721a55b66b3e25ae7eb26da6ffc3dc61
https://pure.au.dk/portal/da/publications/a-52week-randomized-safety-study-of-a-calcipotriolbetamethasone-dipropionate-twocompound-product-dovobetdaivobettaclonex-in-the-treatment-of-psoriasis-vulgaris(93241d50-4fa4-11db-bee9-02004c4f4f50).html
https://pure.au.dk/portal/da/publications/a-52week-randomized-safety-study-of-a-calcipotriolbetamethasone-dipropionate-twocompound-product-dovobetdaivobettaclonex-in-the-treatment-of-psoriasis-vulgaris(93241d50-4fa4-11db-bee9-02004c4f4f50).html